| P50 | author | Heather A Boger | Q89703019 |
| | Ann-Charlotte Granholm | Q130899912 |
| | Alejandra M Pacchioni | Q57046269 |
| P2093 | author name string | Kennerly S Patrick | |
| | Emily D Denehy | |
| | Lawrence D Middaugh | |
| | Sammanda Ramamoorthy | |
| | Jacqueline F McGinty | |
| | Haojie Zhu | |
| P2860 | cites work | Defects in enteric innervation and kidney development in mice lacking GDNF | Q24317594 |
| | GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 |
| | Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age | Q24564422 |
| | Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure | Q28145614 |
| | Renal and neuronal abnormalities in mice lacking GDNF | Q28508969 |
| | Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. | Q30432694 |
| | Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine | Q71128882 |
| | The dopamine transporter: immunochemical characterization and localization in brain | Q71680903 |
| | Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum | Q71686981 |
| | Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse | Q72153646 |
| | DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats | Q73210564 |
| | Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion | Q31873597 |
| | Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. | Q32068809 |
| | Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats | Q33745707 |
| | Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice | Q33915570 |
| | The role of the locus coeruleus in the development of Parkinson's disease | Q34001587 |
| | Putting a spin on the dorsal-ventral divide of the striatum. | Q34335471 |
| | Imaging end points for monitoring neuroprotection in Parkinson's disease. | Q35094903 |
| | Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption | Q35188780 |
| | Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamine | Q36349365 |
| | A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra | Q40247260 |
| | GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon | Q40335801 |
| | A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. | Q40474351 |
| | The noradrenergic system of aged GDNF heterozygous mice. | Q40641126 |
| | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease | Q40846012 |
| | Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. | Q40885664 |
| | Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey | Q40902503 |
| | Regulation of the transmitter phenotype of rostral and caudal groups of cultured serotonergic raphe neurons | Q40961743 |
| | GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine. | Q40974397 |
| | Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily | Q41120968 |
| | GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. | Q41144843 |
| | Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. | Q41345669 |
| | Blockade of methamphetamine-induced depression of tyrosine hydroxylase by GABA transaminase inhibitors | Q42240998 |
| | Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome | Q42527629 |
| | Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine | Q44745333 |
| | Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence | Q44750276 |
| | Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations | Q44750807 |
| | Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study | Q44794339 |
| | Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. | Q44842402 |
| | Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation | Q44911128 |
| | Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines | Q45036507 |
| | High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. | Q45188930 |
| | Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease | Q45266683 |
| | The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. | Q45274123 |
| | Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression | Q45359210 |
| | Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging | Q47831400 |
| | Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys | Q48346991 |
| | The effects of methamphetamine on the production of free radicals and oxidative stress | Q48379473 |
| | Understanding cell death in parkinson's disease | Q48389460 |
| | Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats | Q48447089 |
| | The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum | Q48529338 |
| | The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems | Q48614166 |
| | Evidence that an accumbens to subpallidal GABAergic projection contributes to locomotor activity | Q48743306 |
| | Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain | Q48968033 |
| | Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain | Q49152400 |
| | N-Methyl-D-aspartate receptors and p38 mitogen-activated protein kinase are required for cAMP-dependent cyclase response element binding protein and Elk-1 phosphorylation in the striatum | Q49160543 |
| | Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity | Q51757758 |
| | The organization of the projection from the cerebral cortex to the striatum in the rat. | Q53799354 |
| | Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model | Q67243728 |
| | Age-related changes in human D1 dopamine receptors measured by positron emission tomography | Q67898218 |
| P433 | issue | 33 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heterozygosity | Q124059385 |
| P304 | page(s) | 8816-8825 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice | |
| P478 | volume | 27 | |